Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
language:"Undetermined"
topic_facet:"Medical Condition: Non-relapsing Secondary Progressive Multiple Sclerosis MedDRA version: 21.1Level: PTClassification code 10063400Term: Secondary progressive multiple sclerosisSystem Organ Class: 10029205 - Nervous system disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=language%3A%22Undetermined%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Non-relapsing+Secondary+Progressive+Multiple+Sclerosis+MedDRA+version%3A+21.1Level%3A+PTClassification+code+10063400Term%3A+Secondary+progressive+multiple+sclerosisSystem+Organ+Class%3A+10029205+-+Nervous+system+disorders%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Nervous+System+Diseases+%5BC10%5D%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
/vufind/Search/Results?filter%5B%5D=language%3A%22Undetermined%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Non-relapsing+Secondary+Progressive+Multiple+Sclerosis+MedDRA+version%3A+21.1Level%3A+PTClassification+code+10063400Term%3A+Secondary+progressive+multiple+sclerosisSystem+Organ+Class%3A+10029205+-+Nervous+system+disorders%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Nervous+System+Diseases+%5BC10%5D%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=language%3A%22Undetermined%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Non-relapsing+Secondary+Progressive+Multiple+Sclerosis+MedDRA+version%3A+21.1Level%3A+PTClassification+code+10063400Term%3A+Secondary+progressive+multiple+sclerosisSystem+Organ+Class%3A+10029205+-+Nervous+system+disorders%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Nervous+System+Diseases+%5BC10%5D%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
PubPharm (26)
1
Nonrelapsing secondary progressive multiple sclerosis (NRSPMS) study of Bruton tyrosine kinase (BTK) inhibitor tolebrutinib SAR442168 (HERCULES) : A Phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with nonrelapsing secondary progressive multiple sclerosis - HERCULES
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Nonrelapsing secondary progressive multiple sclerosis (NRSPMS) study of Bruton tyrosine kinase (BTK) inhibitor tolebrutinib SAR442168 (HERCULES) : A Phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with nonrelapsing secondary progressive multiple sclerosis - HERCULES
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Nonrelapsing secondary progressive multiple sclerosis (NRSPMS) study ofBruton tyrosine kinase (BTK) inhibitor tolebrutinib SAR442168(HERCULES) : A Phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with nonrelapsing secondary progressive multiple sclerosis - HERCULES
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
4
Nonrelapsing secondary progressive multiple sclerosis (NRSPMS) study of Bruton tyrosine kinase (BTK) inhibitor tolebrutinib SAR442168 (HERCULES) : A Phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with nonrelapsing secondary progressive multiple sclerosis - HERCULES
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
5
Nonrelapsing secondary progressive multiple sclerosis (NRSPMS) study of Bruton tyrosine kinase (BTK) inhibitor tolebrutinib SAR442168 (HERCULES) : A Phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with nonrelapsing secondary progressive multiple sclerosis - HERCULES
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
6
Nonrelapsing secondary progressive multiple sclerosis (NRSPMS) study ofBruton tyrosine kinase (BTK) inhibitor tolebrutinib SAR442168(HERCULES) : A Phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with nonrelapsing secondary progressive multiple sclerosis - HERCULES
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
7
Nonrelapsing secondary progressive multiple sclerosis (NRSPMS) study of Bruton tyrosine kinase (BTK) inhibitor tolebrutinib SAR442168 (HERCULES) : A Phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with nonrelapsing secondary progressive multiple sclerosis - HERCULES
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
8
Nonrelapsing secondary progressive multiple sclerosis (NRSPMS) study of Bruton tyrosine kinase (BTK) inhibitor tolebrutinib SAR442168 (HERCULES) : A Phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with nonrelapsing secondary progressive multiple sclerosis - HERCULES
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
9
NRSPMS study of Bruton tyrosine kinase (BTK) inhibitor SAR442168 (HERCULES) : A Phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with nonrelapsing secondary progressive multiple sclerosis - HERCULES
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
10
NRSPMS study of Bruton tyrosine kinase (BTK) inhibitor SAR442168 (HERCULES) : A Phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with nonrelapsing secondary progressive multiple sclerosis - HERCULES
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Sprache: Unbestimmt
Filter aufheben
Thema: Medical Condition: Non-relapsing Secondary Progressive Multiple Sclerosis MedDRA version: 21.1Level: PTClassification code 10063400Term: Secondary progressive multiple sclerosisSystem Organ Class: 10029205 - Nervous system disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
Medienart
26
Aufsätze
26
E-Artikel
26
E-Ressourcen
Zeitschriftentitel
26
WHO International Clinical Trials Registry Plat...
Thema
26
610
Medical Condition: Non-relapsing Secondary Prog...
26
Phase: Phase 3
26
Recruitment Status: Authorised-recruitment may ...
26
Study Type: Interventional
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2
2023
12
2022
10
2021
2
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
Unbestimmt
Haven't found what you're looking for?
Wird geladen...